Evaluating abnormal bleeding in perimenopause
Part of Women’s health & pregnancy clinical trials.
This study compares different ways to evaluate abnormal uterine bleeding in women aged 40-55 who are perimenopausal. It aims to find the best method to diagnose the cause of bleeding.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 55 years old.
- You have had abnormal uterine bleeding (heavy or irregular periods) for more than 3 months.
- You do not have an ovarian cyst or growth, or a vaginal or cervical ulcer.
- You are not postmenopausal (bleeding stopped for 12 months or more).
- You do not have diabetes, high blood pressure, or chronic liver disease that is causing the bleeding.
- You are not on hormone therapy or using an intrauterine device (IUD).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the inside of the uterus with a camera (hysteroscopy) and takes a small tissue sample (biopsy) in women who have bleeding after menopause. It aims to understand what might be causing the bleeding.
This study is looking at women who have unusual bleeding or bleeding after menopause to find better ways to diagnose reproductive cancers like endometrial cancer. If you are 45 or older and still have your uterus, you may be able to help.
This early-stage study tests medicines that may help control heavy uterine bleeding by changing how blood clots work in the uterus. If you have regular periods and meet the setup rules, you may be asked to provide menstrual tracking and undergo an endometrial (uterine lining) biopsy.
This study measures hormones in urine to understand why some women have abnormal uterine bleeding and whether it increases cancer risk. It may help doctors better predict and prevent uterine cancer in the future.
This study tests a minimally invasive surgical procedure to treat heavy menstrual bleeding caused by thickened uterine muscle tissue. The goal is to reduce bleeding and improve quality of life in women who haven't benefited from medication alone.
This trial tests a new way to take a small sample of the womb lining (biopsy) using a thin, flexible tube guided by ultrasound. The goal is to see if ultrasound guidance makes the biopsy more accurate and comfortable in people with post-menopausal bleeding.
Hear when a new Perimenopausal Bleeding trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.